Overview

Study of HTD4010 in Healthy Volunteers

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To investigate safety and tolerability of HTD4010 after single ascending doses (SAD) in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
HighTide Biopharma Pty Ltd